Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 347

Similar articles for PubMed (Select 12842303)

1.

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.

Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.

Biol Psychiatry. 2003 Jul 1;54(1):9-16.

PMID:
12842303
2.

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.

Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A.

Am J Psychiatry. 2001 Feb;158(2):282-8.

PMID:
11156812
3.

Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder.

Chang K, Nayar D, Howe M, Rana M.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):547-51. doi: 10.1089/cap.2009.0030.

PMID:
19877979
4.

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.

Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG.

Biol Psychiatry. 2005 Apr 1;57(7):793-801.

PMID:
15820237
5.

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS.

Ann Clin Psychiatry. 2001 Sep;13(3):129-34.

PMID:
11791949
7.

Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.

Findling RL, Schwartz MA, Flannery DJ, Manos MJ.

J Clin Psychiatry. 1996 May;57(5):184-9.

PMID:
8626348
8.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
9.
10.

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.

Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L.

J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):307-14.

PMID:
11288772
12.

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.

DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF.

J Clin Psychopharmacol. 2003 Feb;23(1):27-30.

PMID:
12544372
13.

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.

Wilens TE, Biederman J, Spencer TJ, Frazier J, Prince J, Bostic J, Rater M, Soriano J, Hatch M, Sienna M, Millstein RB, Abrantes A.

J Clin Psychopharmacol. 1999 Jun;19(3):257-64.

PMID:
10350032
14.

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV.

Drug Alcohol Depend. 2006 Feb 1;81(2):137-48. Epub 2005 Aug 15.

PMID:
16102908
15.

An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.

Riggs PD, Leon SL, Mikulich SK, Pottle LC.

J Am Acad Child Adolesc Psychiatry. 1998 Dec;37(12):1271-8.

PMID:
9847499
16.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
17.
18.

Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.

Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, Pollack MH, Ostacher MJ, Yan L, Siegel R, Sachs GS; STEP-BD Investigators.

Biol Psychiatry. 2005 Jun 1;57(11):1467-73.

PMID:
15950022
19.

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.

Adler LA, Zimmerman B, Starr HL, Silber S, Palumbo J, Orman C, Spencer T.

J Clin Psychopharmacol. 2009 Jun;29(3):239-47. doi: 10.1097/JCP.0b013e3181a390ce.

PMID:
19440077
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk